DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Nauck M, Meininger G, Sheng Do. et al
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin,
compared with the sulfonylurea, glipizide, in patients with type 2 diabetes
inadequately controlled on metformin alone: a randomized, double-blind,
non-inferiority trial.
Diabetes, Obesity and Metabolism 2007;
9: 194-205
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.